Furthermore, by reducing the m6A level of 3’UTR and mRNA stability of two phosphodiesterase genes (PDE1C and PDE4B), FTO enhanced second messenger cAMP signaling and inhibited the stemness characteristics of ovarian cancer cells (210). This evidence concerns the gene FTO and ovarian cancer.